Skip to main content

Indian Journal of Hematology and Blood Transfusion

Ausgabe 2/2021

Inhalt (26 Artikel)

Original Article

Response to Immunosuppressive Therapy in Acquired Aplastic Anaemia: Experience of a Tertiary Care Centre from Eastern India

Bijita Dutta, Tuphan Kanti Dolai, Prakas Kumar Mandal, ShuvraNeel Baul, Rajib De, Karthika Senthil, Prantar Chakrabarti

Original Article

Markers of Thrombin Generation and Inflammation in Patients with Paroxysmal Nocturnal Hemoglobinuria

Rishi Dhawan, Jasmina Ahluwalia, Pankaj Malhotra, Manoranjan Mahapatra, Neelam Varma, Subhash Varma

Original Article

Association of Interleukin-1β-31C/T, -511T/C and -3954C/T Single Nucleotide Polymorphism and Their Blood Plasma Level in Acquired Aplastic Anemia

Saurabh Shukla, Anil Kumar Tripathi, Shailendra Prasad Verma, Deependra Kumar Yadav, R. K. Tripathi, Shweta Maurya, Nidhi Awasthi

Original Article

Clinico-Hematological Profile of Paroxysmal Nocturnal Hemoglobinuria in Indian Patients: FLAER Flow Cytometry Based Experience from an Indian Tertiary Care Centre

Priyanka Mishra, Preeti Tripathi, Rohan Halder, Renu Saxena, Seema Tyagi, Manoranjan Mahapatra, H. P. Pati

Original Article

Clinico-Pathologic Profile and Treatment Outcomes of Patients with Diffuse Large B Cell Lymphoma Based on Cell of Origin Classification

Sohan Singh Mandloi, Divya Bala Thumaty, Yadav Nisha, Smita Kayal, Prasanth Ganesan, Sajini Elizabeth Jacob, Debdatta Basu, Biswajit Dubashi

Original Article

Downregulation of MIR100HG Induces Apoptosis in Human Megakaryoblastic Leukemia Cells

Parisa Bagheri, Mohammadreza Sharifi, Ava Ghadiri

Original Article

Primary Bone Lymphoma: A 13 Year Retrospective Institutional Analysis in the Chemo-Immunotherapy Era

Archana Sharma, Rayaz Ahmed, Narendra Agrawal, Jyotsna Kapoor, Anurag Sharma, Vishvdeep Khushoo, Pragya Agrawal, Dinesh Bhurani, Sumeet P. Mirgh

Original Article

Evaluation of LKB1 and Serine-Glycine Metabolism Pathway Genes (SHMT1 and GLDC) Expression in AML

Fateme Mezginejad, Mohammad Hossein Mohammadi, Parinaz khadem, Mehdi Allahbakhshian Farsani

Original Article

Performance of HScore in Reactive Hemophagocytic Lymphohistiocytosis

Neerav Khare, Sree Rekha Jinkala, Srikanta Kanungo

Original Article

The Outcome of Acute Lymphoblastic Leukemia in 109 Adult Iraqi Patients

Dyna Jaza Mohammed, Sana Dlawar Jalal, Ahmed Khudair Yassin, Ali Ibrahim Mohammed, Nasir Abdulsalam Al-Allawi

Original Article

Analysis of the Expression of the TRBC1 in T lymphocyte tumors

Man Chen, Aixian Wang, Shuqiang Liu, Xueying Wu, Meiwei Gong, Junyi Zhen, Minjing Fu, Hui Wang

Original Article

Disease Knowledge and General Self-Efficacy Among Adolescents with Thalassemia Major and Their Parents’ Perspective

Rekha Kharyal, Vanita Kumari, V. T. Mrunalini, Monika Naik, Poonam Joshi, Tulika Seth

Original Article

Low Dose Iron Therapy in Children with Iron Deficiency: DNA Damage and Oxidant Stress Markers

Hanan M. Hamed, Ayat A. Motawie, Amany M. Abd Al-Aziz, Gamila S. M. El-saeed, Maha El Wasseif, Abbass A. Mourad, Hassan M. Salama, Eman Mahmoud Hassan, Neveen A. Helmy, Eman Elghoroury

Original Article

The Play of Citrate Infusion with Calcium in Plateletpheresis Donors

Trupti Lokhande, Sherin Thomas, Guresh Kumar, Meenu Bajpai

Original Article

Screening for Human Parvovirus B19 Infection in Egyptian Family Replacement Blood Donors

Rabab Hasanain Ahmed Hasanain, Rania M. Saleh, Fadia M. Attia, Hanaa H. Gomaa

Short Communication

Efficacy, safety, and quality of life of generic and innovator ibrutinib in Indian CLL patients

Charanpreet Singh, Nishant Jindal, Padma Youron, Pankaj Malhotra, Gaurav Prakash, Alka Khadwal, Arihant Jain, Sreejesh Sreedharanunni, Man Updesh Singh Sachdeva, Shano Naseem, Neelam Varma, Subhash Varma, Deepesh P. Lad

Short Communication

Role of Therapeutic Plasma Exchange in Resolution of Hyperhemolysis in a Patient Living with HIV/AIDS (PLHA) Diagnosed with Paroxysmal Cold Haemoglobinuria: A Case Report”

Anubhav Gupta, Kiran Chaudhary, Ajay Bhatta, Bishakha Swain, Hari Prasad, Brinda Kakkar, Swati Asati

Correspondence

Hb Brugg [HBA1:c.63C>A]: Report of an Ultra-Rare Variant Hemoglobin and Its Co-inheritance with Hb D-Punjab

Abhishek Sharma, Reena Das, Alka Rani Khadwal, Jasbir Kaur Hira, Sanjeev Chhabra, Verinder Kumar, Prashant Sharma

Correspondence

Myeloid Neoplasm with t(8;22)(p11;q11): A Mimicker of Chronic Myeloid Leukaemia in Blast Crisis

Gargi Kapatia, Arun Sasikumar Nair Remani, Shano Naseem, Mayur Parihar, Sreejesh Sreedharanunni

Correspondence

Large Fibrinous Coagulum in the Platelet Bag: A Hint Towards Bacterial Contamination

Anubhav Gupta, Kiran Chaudhary, Anupa Pokhrel, Prerna Sachdeva, Shilpi Varshney, Harkiran Arora, Swati Asati

Images

Histoplasma capsulatum in the Peripheral Blood Smear: A Rare Occurrence

Sujata Sarangi, Arjun, Deepak Kumar, Abhishek Purohit

Images

Unusual Visitor in Bone Marrow—Metastatic Malignant Melanoma

Vinita Paswan, Dinesh Chandra, Ruchi Gupta, Sumaira Qayoom, Soniya Nityanand

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.